Found 119 hits Enz. Inhib. hit(s) with all data for entry = 7973 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226282
(US9321790, 94)Show SMILES CC(=O)N1CCC(CN2[C@@H](CCn3c2nc(cc3=O)N2C[C@@H]3C[C@H]2CO3)C(F)(F)F)CC1 |TLB:15:19:24.25:22| Show InChI InChI=1S/C21H28F3N5O3/c1-13(30)26-5-2-14(3-6-26)10-29-17(21(22,23)24)4-7-27-19(31)9-18(25-20(27)29)28-11-16-8-15(28)12-32-16/h9,14-17H,2-8,10-12H2,1H3/t15-,16-,17-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 130 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226283
(US9321790, 95)Show SMILES FC(F)(F)C1CCn2c(nc(cc2=O)N2C[C@@H]3C[C@H]2CO3)N1CC1CCN(CC1)C=O |THB:10:14:20.19:17| Show InChI InChI=1S/C20H26F3N5O3/c21-20(22,23)16-3-6-26-18(30)8-17(27-10-15-7-14(27)11-31-15)24-19(26)28(16)9-13-1-4-25(12-29)5-2-13/h8,12-16H,1-7,9-11H2/t14-,15-,16?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 180 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226271
(US9321790, 83)Show SMILES Oc1ccc(CCN2[C@@H](CCn3c2nc(cc3=O)N2CC3CCC(C2)O3)C(F)(F)F)cc1 |TLB:14:18:21.22:25| Show InChI InChI=1S/C22H25F3N4O3/c23-22(24,25)18-8-10-29-20(31)11-19(27-12-16-5-6-17(13-27)32-16)26-21(29)28(18)9-7-14-1-3-15(30)4-2-14/h1-4,11,16-18,30H,5-10,12-13H2/t16?,17?,18-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 190 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226272
(US9321790, 84)Show SMILES Cc1c(nc2N(CCCc3ccccc3)[C@@H](CCn2c1=O)C(F)(F)F)N1CC2CCC(C1)O2 |TLB:2:25:28.29:32| Show InChI InChI=1S/C24H29F3N4O2/c1-16-21(29-14-18-9-10-19(15-29)33-18)28-23-30(12-5-8-17-6-3-2-4-7-17)20(24(25,26)27)11-13-31(23)22(16)32/h2-4,6-7,18-20H,5,8-15H2,1H3/t18?,19?,20-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226266
(US9321790, 78)Show SMILES CN(C)CCCOc1ccc(CCN2c3nc(cc(=O)n3C[C@@]2(C)C(F)(F)F)N2CC3CCC(C2)O3)cc1 |TLB:16:28:31.32:35| Show InChI InChI=1S/C27H36F3N5O3/c1-26(27(28,29)30)18-34-24(36)15-23(33-16-21-9-10-22(17-33)38-21)31-25(34)35(26)13-11-19-5-7-20(8-6-19)37-14-4-12-32(2)3/h5-8,15,21-22H,4,9-14,16-18H2,1-3H3/t21?,22?,26-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 250 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226299
(US9321790, 111)Show SMILES FC(F)(F)[C@@H]1CCn2c(nc(cc2=O)N2C[C@@H]3C[C@H]2CO3)N1CCc1ccc(OCCN2CCOCC2)cc1 |TLB:10:14:19.20:17| Show InChI InChI=1S/C27H34F3N5O4/c28-27(29,30)23-6-8-34-25(36)16-24(35-17-22-15-20(35)18-39-22)31-26(34)33(23)7-5-19-1-3-21(4-2-19)38-14-11-32-9-12-37-13-10-32/h1-4,16,20,22-23H,5-15,17-18H2/t20-,22-,23-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 330 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226270
(US9321790, 82)Show SMILES O[C@H](CN1[C@@H](CCn2c1nc(cc2=O)N1CC2CCC(C1)O2)C(F)(F)F)c1cc2ccccc2s1 |TLB:10:14:17.18:21| Show InChI InChI=1S/C24H25F3N4O3S/c25-24(26,27)20-7-8-30-22(33)10-21(29-11-15-5-6-16(12-29)34-15)28-23(30)31(20)13-17(32)19-9-14-3-1-2-4-18(14)35-19/h1-4,9-10,15-17,20,32H,5-8,11-13H2/t15?,16?,17-,20+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 340 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226305
(US9321790, 117)Show SMILES CN(C)CCOc1ccc(CCN2[C@@H](CCn3c2nc(cc3=O)N2C[C@@H]3C[C@H]2CO3)C(F)(F)F)cc1 |TLB:19:23:28.29:26| Show InChI InChI=1S/C25H32F3N5O3/c1-30(2)11-12-35-19-5-3-17(4-6-19)7-9-31-21(25(26,27)28)8-10-32-23(34)14-22(29-24(31)32)33-15-20-13-18(33)16-36-20/h3-6,14,18,20-21H,7-13,15-16H2,1-2H3/t18-,20-,21-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 380 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226285
(US9321790, 97)Show SMILES OC(CCN1C(CCn2c1nc(cc2=O)N1C[C@@H]2C[C@H]1CO2)C(F)(F)F)(C(F)(F)F)C(F)(F)F |THB:11:15:21.20:18| Show InChI InChI=1S/C18H19F9N4O3/c19-16(20,21)11-1-3-30-13(32)6-12(31-7-10-5-9(31)8-34-10)28-14(30)29(11)4-2-15(33,17(22,23)24)18(25,26)27/h6,9-11,33H,1-5,7-8H2/t9-,10-,11?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 440 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226280
(US9321790, 92)Show SMILES FC(F)(F)C1CCn2c(nc(cc2=O)N2C[C@@H]3C[C@H]2CO3)N1CCC1CCOCC1 |THB:10:14:20.19:17| Show InChI InChI=1S/C20H27F3N4O3/c21-20(22,23)16-2-6-26-18(28)10-17(27-11-15-9-14(27)12-30-15)24-19(26)25(16)5-1-13-3-7-29-8-4-13/h10,13-16H,1-9,11-12H2/t14-,15-,16?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 450 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226289
(US9321790, 101)Show SMILES OC1(CN2[C@@H](CCn3c2nc(cc3=O)N2C[C@@H]3C[C@H]2CO3)C(F)(F)F)CCCC1 |TLB:10:14:19.20:17| Show InChI InChI=1S/C19H25F3N4O3/c20-19(21,22)14-3-6-24-16(27)8-15(25-9-13-7-12(25)10-29-13)23-17(24)26(14)11-18(28)4-1-2-5-18/h8,12-14,28H,1-7,9-11H2/t12-,13-,14-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 450 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226303
(US9321790, 115)Show SMILES FC(F)(F)[C@@H]1CCn2c(nc(cc2=O)N2C[C@@H]3C[C@H]2CO3)N1CCc1ccc(OCC(=O)N2CCOCC2)cc1 |TLB:10:14:19.20:17| Show InChI InChI=1S/C27H32F3N5O5/c28-27(29,30)22-6-8-34-24(36)14-23(35-15-21-13-19(35)16-39-21)31-26(34)33(22)7-5-18-1-3-20(4-2-18)40-17-25(37)32-9-11-38-12-10-32/h1-4,14,19,21-22H,5-13,15-17H2/t19-,21-,22-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 590 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226260
(US9321790, 72)Show SMILES C[C@]1(Cn2c(nc(cc2=O)N2CC3CCC(C2)O3)N1CCc1ccc(O)cc1)C(F)(F)F |TLB:6:10:13.14:17| Show InChI InChI=1S/C22H25F3N4O3/c1-21(22(23,24)25)13-28-19(31)10-18(27-11-16-6-7-17(12-27)32-16)26-20(28)29(21)9-8-14-2-4-15(30)5-3-14/h2-5,10,16-17,30H,6-9,11-13H2,1H3/t16?,17?,21-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 730 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226281
(US9321790, 93)Show SMILES FC(F)(F)C1CCn2c(nc(cc2=O)N2C[C@@H]3C[C@H]2CO3)N1CC1CCOCC1 |THB:10:14:20.19:17| Show InChI InChI=1S/C19H25F3N4O3/c20-19(21,22)15-1-4-24-17(27)8-16(25-10-14-7-13(25)11-29-14)23-18(24)26(15)9-12-2-5-28-6-3-12/h8,12-15H,1-7,9-11H2/t13-,14-,15?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 780 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226259
(US9321790, 71)Show SMILES COc1cc(F)ccc1[C@H](O)CN1[C@@H](CCn2c1nc(cc2=O)N1CC2CCC(C1)O2)C(F)(F)F |TLB:19:23:26.27:30| Show InChI InChI=1S/C23H26F4N4O4/c1-34-18-8-13(24)2-5-16(18)17(32)12-31-19(23(25,26)27)6-7-30-21(33)9-20(28-22(30)31)29-10-14-3-4-15(11-29)35-14/h2,5,8-9,14-15,17,19,32H,3-4,6-7,10-12H2,1H3/t14?,15?,17-,19+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 810 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226265
(US9321790, 77)Show SMILES C[C@]1(Cn2c(nc(cc2=O)N2CC3CCC(C2)O3)N1CCCc1ccccc1)C(F)(F)F |TLB:6:10:13.14:17| Show InChI InChI=1S/C23H27F3N4O2/c1-22(23(24,25)26)15-29-20(31)12-19(28-13-17-9-10-18(14-28)32-17)27-21(29)30(22)11-5-8-16-6-3-2-4-7-16/h2-4,6-7,12,17-18H,5,8-11,13-15H2,1H3/t17?,18?,22-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 820 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226262
(US9321790, 74)Show SMILES CN(C)CCOc1ccc(CCN2c3nc(cc(=O)n3C[C@@]2(C)C(F)(F)F)N2CC3CCC(C2)O3)cc1 |TLB:15:27:30.31:34| Show InChI InChI=1S/C26H34F3N5O3/c1-25(26(27,28)29)17-33-23(35)14-22(32-15-20-8-9-21(16-32)37-20)30-24(33)34(25)11-10-18-4-6-19(7-5-18)36-13-12-31(2)3/h4-7,14,20-21H,8-13,15-17H2,1-3H3/t20?,21?,25-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 820 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226291
(US9321790, 103)Show SMILES OC(CN1[C@@H](CCn2c1nc(cc2=O)N1C[C@@H]2C[C@H]1CO2)C(F)(F)F)(C1CC1)C1CC1 |TLB:10:14:19.20:17| Show InChI InChI=1S/C21H27F3N4O3/c22-21(23,24)16-5-6-26-18(29)8-17(27-9-15-7-14(27)10-31-15)25-19(26)28(16)11-20(30,12-1-2-12)13-3-4-13/h8,12-16,30H,1-7,9-11H2/t14-,15-,16-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 840 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226292
(US9321790, 104)Show SMILES OC1(CN2[C@@H](CCn3c2nc(cc3=O)N2C[C@@H]3C[C@H]2CO3)C(F)(F)F)CC1 |TLB:10:14:19.20:17| Show InChI InChI=1S/C17H21F3N4O3/c18-17(19,20)12-1-4-22-14(25)6-13(23-7-11-5-10(23)8-27-11)21-15(22)24(12)9-16(26)2-3-16/h6,10-12,26H,1-5,7-9H2/t10-,11-,12-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 930 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226264
(US9321790, 76)Show SMILES COc1ccc(CCN2c3nc(cc(=O)n3C[C@@]2(C)C(F)(F)F)N2CC3CCC(C2)O3)cc1 |TLB:11:23:26.27:30| Show InChI InChI=1S/C23H27F3N4O3/c1-22(23(24,25)26)14-29-20(31)11-19(28-12-17-7-8-18(13-28)33-17)27-21(29)30(22)10-9-15-3-5-16(32-2)6-4-15/h3-6,11,17-18H,7-10,12-14H2,1-2H3/t17?,18?,22-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 950 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226258
(US9321790, 70)Show SMILES CN(C)C(=O)COc1ccc(CCN2c3nc(cc(=O)n3C[C@@]2(C)C(F)(F)F)N2CC3CCC(C2)O3)cc1 |TLB:16:28:31.32:35| Show InChI InChI=1S/C26H32F3N5O4/c1-25(26(27,28)29)16-33-22(35)12-21(32-13-19-8-9-20(14-32)38-19)30-24(33)34(25)11-10-17-4-6-18(7-5-17)37-15-23(36)31(2)3/h4-7,12,19-20H,8-11,13-16H2,1-3H3/t19?,20?,25-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226213
(US9321790, 25)Show SMILES Cc1ncsc1CCN1[C@@H](CCn2c1nc(cc2=O)N1C[C@@H]2C[C@H]1CO2)C(F)(F)F |TLB:15:19:24.25:22| Show InChI InChI=1S/C19H22F3N5O2S/c1-11-14(30-10-23-11)2-4-25-15(19(20,21)22)3-5-26-17(28)7-16(24-18(25)26)27-8-13-6-12(27)9-29-13/h7,10,12-13,15H,2-6,8-9H2,1H3/t12-,13-,15-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226211
(US9321790, 23)Show SMILES CCNC(=O)Nc1ccc(CCN2C(CCn3c2nc(cc3=O)N2C[C@@H]3C[C@H]2CO3)C(F)(F)F)cc1 |TLB:19:23:28.29:26| Show InChI InChI=1S/C24H29F3N6O3/c1-2-28-22(35)29-16-5-3-15(4-6-16)7-9-31-19(24(25,26)27)8-10-32-21(34)12-20(30-23(31)32)33-13-18-11-17(33)14-36-18/h3-6,12,17-19H,2,7-11,13-14H2,1H3,(H2,28,29,35)/t17-,18-,19?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 1.04E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226276
(US9321790, 88)Show SMILES FC(F)(F)[C@@H]1CCn2c(nc(cc2=O)N2CC3CCC(C2)O3)N1CC(=O)c1ccccn1 |TLB:10:14:17.18:21| Show InChI InChI=1S/C21H22F3N5O3/c22-21(23,24)17-6-8-28-19(31)9-18(27-10-13-4-5-14(11-27)32-13)26-20(28)29(17)12-16(30)15-3-1-2-7-25-15/h1-3,7,9,13-14,17H,4-6,8,10-12H2/t13?,14?,17-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226215
(US9321790, 27)Show SMILES Cc1n[nH]c(C)c1CCN1[C@@H](CCn2c1nc(cc2=O)N1C[C@@H]2C[C@H]1CO2)C(F)(F)F |TLB:16:20:25.26:23| Show InChI InChI=1S/C20H25F3N6O2/c1-11-15(12(2)26-25-11)3-5-27-16(20(21,22)23)4-6-28-18(30)8-17(24-19(27)28)29-9-14-7-13(29)10-31-14/h8,13-14,16H,3-7,9-10H2,1-2H3,(H,25,26)/t13-,14-,16-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 1.53E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226267
(US9321790, 79)Show SMILES C[C@]1(Cn2c(nc(cc2=O)N2CC3CCC(C2)O3)N1C[C@@H](O)c1ccccc1)C(F)(F)F |TLB:6:10:13.14:17| Show InChI InChI=1S/C22H25F3N4O3/c1-21(22(23,24)25)13-28-19(31)9-18(27-10-15-7-8-16(11-27)32-15)26-20(28)29(21)12-17(30)14-5-3-2-4-6-14/h2-6,9,15-17,30H,7-8,10-13H2,1H3/t15?,16?,17-,21+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 1.60E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226268
(US9321790, 80)Show SMILES O[C@H](CN1[C@@H](CCn2c1nc(cc2=O)N1CC2CCC(C1)O2)C(F)(F)F)c1ccccc1 |TLB:10:14:17.18:21| Show InChI InChI=1S/C22H25F3N4O3/c23-22(24,25)18-8-9-28-20(31)10-19(27-11-15-6-7-16(12-27)32-15)26-21(28)29(18)13-17(30)14-4-2-1-3-5-14/h1-5,10,15-18,30H,6-9,11-13H2/t15?,16?,17-,18+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 1.60E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226293
(US9321790, 105)Show SMILES OC1(CCN2[C@@H](CCn3c2nc(cc3=O)N2C[C@@H]3C[C@H]2CO3)C(F)(F)F)CC1 |TLB:11:15:20.21:18| Show InChI InChI=1S/C18H23F3N4O3/c19-18(20,21)13-1-5-24-15(26)8-14(25-9-12-7-11(25)10-28-12)22-16(24)23(13)6-4-17(27)2-3-17/h8,11-13,27H,1-7,9-10H2/t11-,12-,13-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 1.90E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226288
(US9321790, 100)Show SMILES OC1(CCN2[C@@H](CCn3c2nc(cc3=O)N2C[C@@H]3C[C@H]2CO3)C(F)(F)F)CCCC1 |TLB:11:15:20.21:18| Show InChI InChI=1S/C20H27F3N4O3/c21-20(22,23)15-3-7-26-17(28)10-16(27-11-14-9-13(27)12-30-14)24-18(26)25(15)8-6-19(29)4-1-2-5-19/h10,13-15,29H,1-9,11-12H2/t13-,14-,15-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 1.98E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226214
(US9321790, 26)Show SMILES Cc1ncsc1CCN1c2nc(cc(=O)n2CC1(C)C(F)(F)F)N1C[C@@H]2C[C@H]1CO2 |TLB:11:23:28.29:26| Show InChI InChI=1S/C19H22F3N5O2S/c1-11-14(30-10-23-11)3-4-27-17-24-15(25-7-13-5-12(25)8-29-13)6-16(28)26(17)9-18(27,2)19(20,21)22/h6,10,12-13H,3-5,7-9H2,1-2H3/t12-,13-,18?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226269
(US9321790, 81)Show SMILES COc1ccc(CCN2[C@@H](CCn3c2nc(cc3=O)N2CC3CCC(C2)O3)C(F)(F)F)cc1 |TLB:15:19:22.23:26| Show InChI InChI=1S/C23H27F3N4O3/c1-32-16-4-2-15(3-5-16)8-10-29-19(23(24,25)26)9-11-30-21(31)12-20(27-22(29)30)28-13-17-6-7-18(14-28)33-17/h2-5,12,17-19H,6-11,13-14H2,1H3/t17?,18?,19-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226242
(US9321790, 54)Show SMILES CCC(O)(CC)CN1[C@@H](CCn2c1nc(cc2=O)N1C[C@@H]2C[C@H]1CO2)C(F)(F)F |TLB:14:18:23.24:21| Show InChI InChI=1S/C19H27F3N4O3/c1-3-18(28,4-2)11-26-14(19(20,21)22)5-6-24-16(27)8-15(23-17(24)26)25-9-13-7-12(25)10-29-13/h8,12-14,28H,3-7,9-11H2,1-2H3/t12-,13-,14-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 2.21E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226216
(US9321790, 28)Show SMILES Cc1n[nH]c(C)c1CCN1c2nc(cc(=O)n2CC1(C)C(F)(F)F)N1C[C@@H]2C[C@H]1CO2 |TLB:12:24:29.30:27| Show InChI InChI=1S/C20H25F3N6O2/c1-11-15(12(2)26-25-11)4-5-29-18-24-16(27-8-14-6-13(27)9-31-14)7-17(30)28(18)10-19(29,3)20(21,22)23/h7,13-14H,4-6,8-10H2,1-3H3,(H,25,26)/t13-,14-,19?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 2.26E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226278
(US9321790, 90)Show SMILES FC(F)(F)C1CCn2c(nc(cc2=O)N2C[C@@H]3C[C@H]2CO3)N1CCC1CCN(CC1)C=O |THB:10:14:20.19:17| Show InChI InChI=1S/C21H28F3N5O3/c22-21(23,24)17-4-8-28-19(31)10-18(29-11-16-9-15(29)12-32-16)25-20(28)27(17)7-3-14-1-5-26(13-30)6-2-14/h10,13-17H,1-9,11-12H2/t15-,16-,17?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 2.40E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226212
(US9321790, 24)Show SMILES CCNC(=O)Nc1ccc(CCN2c3nc(cc(=O)n3C[C@@]2(C)C(F)(F)F)N2C[C@@H]3C[C@H]2CO3)cc1 |TLB:15:27:32.33:30| Show InChI InChI=1S/C24H29F3N6O3/c1-3-28-21(35)29-16-6-4-15(5-7-16)8-9-33-22-30-19(31-12-18-10-17(31)13-36-18)11-20(34)32(22)14-23(33,2)24(25,26)27/h4-7,11,17-18H,3,8-10,12-14H2,1-2H3,(H2,28,29,35)/t17-,18-,23-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 2.44E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226261
(US9321790, 73)Show SMILES FC(F)(F)[C@@H]1CCn2c(nc(cc2=O)N2CC3CCC(C2)O3)N1CC(=O)c1ccccc1 |TLB:10:14:17.18:21| Show InChI InChI=1S/C22H23F3N4O3/c23-22(24,25)18-8-9-28-20(31)10-19(27-11-15-6-7-16(12-27)32-15)26-21(28)29(18)13-17(30)14-4-2-1-3-5-14/h1-5,10,15-16,18H,6-9,11-13H2/t15?,16?,18-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 2.50E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226290
(US9321790, 102)Show SMILES OC(CCN1[C@@H](CCn2c1nc(cc2=O)N1C[C@@H]2C[C@H]1CO2)C(F)(F)F)(C1CC1)C1CC1 |TLB:11:15:20.21:18| Show InChI InChI=1S/C22H29F3N4O3/c23-22(24,25)17-5-7-28-19(30)10-18(29-11-16-9-15(29)12-32-16)26-20(28)27(17)8-6-21(31,13-1-2-13)14-3-4-14/h10,13-17,31H,1-9,11-12H2/t15-,16-,17-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 2.50E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226237
(US9321790, 49)Show SMILES CCC(O)(CC)CCN1[C@@H](CCn2c1nc(cc2=O)N1C[C@@H]2C[C@H]1CO2)C(F)(F)F |TLB:15:19:24.25:22| Show InChI InChI=1S/C20H29F3N4O3/c1-3-19(29,4-2)6-8-25-15(20(21,22)23)5-7-26-17(28)10-16(24-18(25)26)27-11-14-9-13(27)12-30-14/h10,13-15,29H,3-9,11-12H2,1-2H3/t13-,14-,15-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 2.74E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226277
(US9321790, 89)Show SMILES CC(=O)N1CCC(CCN2[C@@H](CCn3c2nc(cc3=O)N2C[C@@H]3C[C@H]2CO3)C(F)(F)F)CC1 |TLB:16:20:25.26:23| Show InChI InChI=1S/C22H30F3N5O3/c1-14(31)27-6-2-15(3-7-27)4-8-28-18(22(23,24)25)5-9-29-20(32)11-19(26-21(28)29)30-12-17-10-16(30)13-33-17/h11,15-18H,2-10,12-13H2,1H3/t16-,17-,18-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 2.80E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226200
(US9321790, 12)Show SMILES FC(F)(F)C1CCn2c(nc(cc2=O)N2C[C@@H]3C[C@H]2CO3)N1CCc1cccnc1 |THB:10:14:20.19:17| Show InChI InChI=1S/C20H22F3N5O2/c21-20(22,23)16-4-7-27-18(29)9-17(28-11-15-8-14(28)12-30-15)25-19(27)26(16)6-3-13-2-1-5-24-10-13/h1-2,5,9-10,14-16H,3-4,6-8,11-12H2/t14-,15-,16?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 2.90E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226189
(US9321790, 1)Show SMILES CC(C)(CN1[C@@H](CCn2c1nc(cc2=O)N1C[C@@H]2C[C@H]1CO2)C(F)(F)F)c1ccncc1 |TLB:11:15:20.21:18| Show InChI InChI=1S/C22H26F3N5O2/c1-21(2,14-3-6-26-7-4-14)13-30-17(22(23,24)25)5-8-28-19(31)10-18(27-20(28)30)29-11-16-9-15(29)12-32-16/h3-4,6-7,10,15-17H,5,8-9,11-13H2,1-2H3/t15-,16-,17-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 3.13E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226220
(US9321790, 32)Show SMILES CC1(Cn2c(nc(cc2=O)N2C[C@@H]3C[C@H]2CO3)N1CCc1ccc(N)cc1)C(F)(F)F |TLB:6:10:15.16:13| Show InChI InChI=1S/C21H24F3N5O2/c1-20(21(22,23)24)12-28-18(30)9-17(27-10-16-8-15(27)11-31-16)26-19(28)29(20)7-6-13-2-4-14(25)5-3-13/h2-5,9,15-16H,6-8,10-12,25H2,1H3/t15-,16-,20?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 3.70E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226255
(US9321790, 67)Show SMILES FC(F)(F)[C@@H]1CCn2c(nc(cc2=O)N2C[C@@H]3C[C@H]2CO3)N1CC(=O)C1CC1 |TLB:10:14:19.20:17| Show InChI InChI=1S/C18H21F3N4O3/c19-18(20,21)14-3-4-23-16(27)6-15(24-7-12-5-11(24)9-28-12)22-17(23)25(14)8-13(26)10-1-2-10/h6,10-12,14H,1-5,7-9H2/t11-,12-,14-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 4.00E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226229
(US9321790, 41)Show SMILES FC(F)(F)[C@@H]1CCn2c(nc(cc2=O)N2C[C@@H]3C[C@H]2CO3)N1CC(=O)c1ccc(cc1)N1CCOCC1 |TLB:10:14:19.20:17| Show InChI InChI=1S/C25H28F3N5O4/c26-25(27,28)21-5-6-31-23(35)12-22(32-13-19-11-18(32)15-37-19)29-24(31)33(21)14-20(34)16-1-3-17(4-2-16)30-7-9-36-10-8-30/h1-4,12,18-19,21H,5-11,13-15H2/t18-,19-,21-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 4.20E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226238
(US9321790, 50)Show SMILES CC(C)(O)CCN1[C@@H](CCn2c1nc(cc2=O)N1C[C@@H]2C[C@H]1CO2)C(F)(F)F |TLB:13:17:22.23:20| Show InChI InChI=1S/C18H25F3N4O3/c1-17(2,27)4-6-23-13(18(19,20)21)3-5-24-15(26)8-14(22-16(23)24)25-9-12-7-11(25)10-28-12/h8,11-13,27H,3-7,9-10H2,1-2H3/t11-,12-,13-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 4.30E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226201
(US9321790, 13)Show SMILES CC1(Cn2c(nc(cc2=O)N2C[C@@H]3C[C@H]2CO3)N1CCc1cccnc1)C(F)(F)F |TLB:6:10:15.16:13| Show InChI InChI=1S/C20H22F3N5O2/c1-19(20(21,22)23)12-27-17(29)8-16(26-10-15-7-14(26)11-30-15)25-18(27)28(19)6-4-13-3-2-5-24-9-13/h2-3,5,8-9,14-15H,4,6-7,10-12H2,1H3/t14-,15-,19?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 5.75E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226226
(US9321790, 38)Show SMILES FC(F)(F)[C@@H]1CCn2c(nc(cc2=O)N2C[C@@H]3C[C@H]2CO3)N1CC(=O)c1cnc2NCCOc2c1 |TLB:10:14:19.20:17| Show InChI InChI=1S/C22H23F3N6O4/c23-22(24,25)17-1-3-29-19(33)7-18(30-9-14-6-13(30)11-35-14)28-21(29)31(17)10-15(32)12-5-16-20(27-8-12)26-2-4-34-16/h5,7-8,13-14,17H,1-4,6,9-11H2,(H,26,27)/t13-,14-,17-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 5.77E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226219
(US9321790, 31)Show SMILES Cc1cc(cnc1N)C(=O)CN1[C@@H](CCn2c1nc(cc2=O)N1C[C@@H]2C[C@H]1CO2)C(F)(F)F |TLB:18:22:27.28:25| Show InChI InChI=1S/C21H23F3N6O3/c1-11-4-12(7-26-19(11)25)15(31)9-30-16(21(22,23)24)2-3-28-18(32)6-17(27-20(28)30)29-8-14-5-13(29)10-33-14/h4,6-7,13-14,16H,2-3,5,8-10H2,1H3,(H2,25,26)/t13-,14-,16-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 6.35E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226246
(US9321790, 58)Show SMILES COC(=O)Nc1ccc(cn1)C(=O)CN1C(CCn2c1nc(cc2=O)N1C[C@@H]2C[C@H]1CO2)C(F)(F)F |TLB:21:25:30.31:28| Show InChI InChI=1S/C22H23F3N6O5/c1-35-21(34)27-17-3-2-12(8-26-17)15(32)10-31-16(22(23,24)25)4-5-29-19(33)7-18(28-20(29)31)30-9-14-6-13(30)11-36-14/h2-3,7-8,13-14,16H,4-6,9-11H2,1H3,(H,26,27,34)/t13-,14-,16?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 6.40E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM226256
(US9321790, 68)Show SMILES FC(F)(F)C1CCn2c(nc(cc2=O)N2C[C@@H]3C[C@H]2CO3)N1CC(=O)c1ccccn1 |THB:10:14:20.19:17| Show InChI InChI=1S/C20H20F3N5O3/c21-20(22,23)16-4-6-26-18(30)8-17(27-9-13-7-12(27)11-31-13)25-19(26)28(16)10-15(29)14-3-1-2-5-24-14/h1-3,5,8,12-13,16H,4,6-7,9-11H2/t12-,13-,16?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 6.60E+3 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Sanofi
US Patent
| Assay Description The compounds according to the invention underwent pharmacological trials to measure the selectivity toward human lipid kinases and especially human ... |
US Patent US9321790 (2016)
BindingDB Entry DOI: 10.7270/Q2KD1WSG |
More data for this Ligand-Target Pair | |